Forecast Ledgerinterventional psychiatry and psychedelic medicineQuoted, dated predictions scored against public outcomes under one written method. Every score links to the words, the rule and the evidence.

Not admitted · Third-party claim

Rules 1.1.0 · as of 14 Sep 2026

Quote

Third-party claim

“Spravato (esketamine) is now a blockbuster with Johnson & Johnson anticipating more than 3 billion USD revenues in 2027.”
· atai Life Sciences – Strong Phase 2b topline data for BPL-003 (5-MeO-DMT) and further strategic backing · own post

Same section; cites J&J's revenue projection for Spravato.

A quoted or paraphrased claim by someone else that the author does not adopt as their own.